Matinas BioPharma Holdings, Inc. (MTNB)

MTNB Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6.92	7.28	4.79	6.83	21.03	12.43
Short-Term Investments	-	-	8.97	21.93	28.59	46.25
Cash & Short-Term Investments	6.92	7.28	13.76	28.76	49.62	58.68
Cash Growth	-14.62%	-47.05%	-52.18%	-42.04%	-15.43%	111.26%
Prepaid Expenses	0.57	0.69	1.74	5.72	1.32	2.74
Restricted Cash	-	-	-	-	-	0.14
Other Current Assets	0.05	0.05	0.05	0.05	0.05	-
Total Current Assets	7.55	8.03	15.54	34.53	50.99	61.55
Property, Plant & Equipment	2.03	2.16	5.01	5.73	5.78	4.86
Goodwill	-	-	1.34	1.34	1.34	1.34
Long-Term Deferred Charges	2.26	2.26	3.02	3.02	3.02	3.02
Other Long-Term Assets	0.2	0.2	0.2	0.2	0.2	0.2
Total Assets	12.04	12.64	25.1	44.82	61.33	70.97
Accounts Payable	0.28	0.1	0.51	0.62	0.94	0.35
Accrued Expenses	1.18	1.81	1.45	2.29	1.92	2.15
Current Portion of Leases	0.79	0.77	0.66	0.57	0.56	0.42
Current Unearned Revenue	-	-	-	0.72	0.03	0.07
Other Current Liabilities	-	-	-	0.09	0.9	0.58
Total Current Liabilities	2.26	2.67	2.62	4.29	4.35	3.57
Long-Term Leases	1.92	2.13	2.9	3.56	4.14	3.33
Long-Term Deferred Tax Liabilities	0.26	0.26	0.34	0.34	0.34	0.34
Other Long-Term Liabilities	1.33	-	-	-	-	-
Total Liabilities	5.77	5.05	5.86	8.18	8.83	7.24
Common Stock	0	0	-	0.02	0.02	0.02
Additional Paid-In Capital	207.75	207.41	195.04	190.07	184.25	167.19
Retained Earnings	-201.48	-199.82	-175.57	-152.63	-131.63	-107.51
Comprehensive Income & Other	-	-	-0.22	-0.82	-0.15	0.23
Total Common Equity	6.27	7.59	19.25	36.64	52.49	59.93
Shareholders' Equity	6.27	7.59	19.25	36.64	52.49	63.73
Total Liabilities & Equity	12.04	12.64	25.1	44.82	61.33	70.97
Total Debt	2.71	2.89	3.56	4.12	4.7	3.75
Net Cash (Debt)	4.21	4.39	10.2	24.64	44.92	54.93
Net Cash Growth	-10.63%	-56.96%	-58.60%	-45.15%	-18.22%	133.28%
Net Cash Per Share	0.83	0.90	2.35	5.68	10.69	13.95
Filing Date Shares Outstanding	5.09	5.09	4.35	4.35	4.34	4.09
Total Common Shares Outstanding	5.09	5.09	4.35	4.35	4.33	4
Working Capital	5.29	5.36	12.92	30.25	46.65	57.99
Book Value Per Share	1.23	1.49	4.43	8.43	12.14	14.97
Tangible Book Value	6.27	7.59	17.91	35.3	51.16	58.6
Tangible Book Value Per Share	1.23	1.49	4.12	8.12	11.83	14.64
Machinery	0.28	1.54	2.46	2.31	1.64	1.44
Leasehold Improvements	0.22	0.99	1.16	1.16	0.94	0.88

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q